- Home
- BRNS vs ARQQ Comparison
BRNS vs ARQQ Comparison
Compare BRNS & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRNS | ARQQ |
|---|---|---|
| Founded | 2016 | 2017 |
| Country | United States | United Kingdom |
| Employees | N/A | 91 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 220.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BRNS | ARQQ |
|---|---|---|
| Price | $0.68 | $13.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $4.00 | ★ $60.00 |
| AVG Volume (30 Days) | 17.3K | ★ 414.0K |
| Earning Date | 05-07-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $381.13 |
| Revenue Next Year | N/A | $212.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $11.52 |
| 52 Week High | $2.91 | $62.00 |
Technical Indicators
Market Signals| Indicator | BRNS | ARQQ |
|---|---|---|
| Relative Strength Index (RSI) | 60.62 | 45.32 |
| Support Level | $0.66 | $13.04 |
| Resistance Level | $0.76 | $17.75 |
| Average True Range (ATR) | 0.05 | 1.03 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 66.18 | 30.43 |
Price Performance
Historical ComparisonAbout BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.